QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

ZBHTICKER

Zimmer Biomet Holdings, Inc.

VERY BULLISH stock

Congress has disclosed 24 buys and 17 sells of ZBH (Zimmer Biomet Holdings, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

24
Buy
17
Sell
+7
Net
10
Active politicians

Round-trip watch Still on the books

Members who disclosed buying ZBH and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Rohit Khanna 2026-09-11 $93.24 $94.58 +1.4% ↩ near entry
Alan Armstrong 2026-03-27 $87.86 $94.58 +7.6% in profit

Price as of 2026-11-02. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
22.37
▼ cheaper than Health (median 29.7)
how it's calculated
P/E = price ÷ earnings per share
$94.58 ÷ $4.23 = 22.37
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
1.43
▼ cheaper than Health (median 4.4)
how it's calculated
P/B = price ÷ book value per share
$94.58 ÷ $66.18 = 1.43
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
10.92
▼ cheaper than Health (median 16.2)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($18.0B + $7.1B net debt) ÷ $2.3B = $25.1B ÷ $2.3B = 10.92
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

Legislation Related Legislation

Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.

BillTitlePolicy areaLatest action
HR 10887 Protecting Consumer Access to Generic Drugs Act of 2026 Health 2026-10-22
HR 10874 Medicare Low Income Subsidy Equality Act of 2026 Health 2026-10-22
HR 10858 CARE for Blood Cancer Act of 2026 Health 2026-10-22
HR 10810 National Patient Safety Board Act of 2026 Health 2026-10-15
HR 10824 Stroke Education and EMS Care Improvement Act of 2026 Health 2026-10-15

41 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Rohit Khanna House SELL OCR ◆ insider convergence Child 2026-09-14 17 days -8.5% $1K–$15K 58.7 ↗ filing
Rohit Khanna House BUY OCR ◆ insider divergence Child 2026-09-11 20 days -5.6% $1K–$15K 54.6 ↗ filing
Rohit Khanna House SELL OCR ◆ insider convergence · moderate Child 2026-07-23 11 days +8.2% $1K–$15K 25.7 ↗ filing
Rohit Khanna House SELL OCR ◆ insider convergence Child 2026-07-06 28 days +8.0% $1K–$15K 19.0 ↗ filing
Alan Armstrong Senate BUY ◆ insider divergence Self 2026-03-27 116 days +0.9% $1K–$15K 99.1 ↗ eFD
Rohit Khanna House SELL OCR ◆ insider convergence Child 2026-02-17 15 days -1.4% $1K–$15K 5.1 ↗ filing
Rohit Khanna House BUY OCR ◆ insider divergence Child 2025-07-09 23 days -4.8% $1K–$15K 3.9 ↗ filing
Rohit Khanna House BUY OCR ◆ insider divergence Child 2025-06-10 27 days -2.2% $1K–$15K 3.9 ↗ filing
Rob Bresnahan House SELL ◆ insider convergence Self · JP Morgan Brokerage Account 2025-05-15 0 days 0.0% $1K–$15K
0.2% of NW
33.6 ↗ filing
Rohit Khanna House SELL OCR ◆ insider convergence Child 2025-05-02 38 days -9.3% $1K–$15K 12.3 ↗ filing
Rob Bresnahan House BUY ◆ insider divergence Self · JP Morgan Brokerage Account 2025-04-08 0 days 0.0% $1K–$15K
0.2% of NW
64.4 ↗ filing
Rohit Khanna House SELL OCR ◆ insider convergence Child 2025-04-04 34 days -11.4% $1K–$15K 2.6 ↗ filing
Julie Johnson House SELL ◆ insider convergence Joint · Merrill Lynch Long Term Growth 2025-02-11 23 days +6.4% $1K–$15K
<0.1% of NW
62.6 ↗ filing
Rohit Khanna House BUY OCR Child 2024-11-15 19 days -1.7% $1K–$15K 2.6 ↗ filing
Rohit Khanna House BUY OCR ◆ insider divergence Spouse 2024-06-12 20 days — $1K–$15K 4.5 ↗ filing
Rohit Khanna House BUY OCR ◆ insider divergence Child 2024-05-29 6 days — $1K–$15K 5.5 ↗ filing
Rohit Khanna House BUY OCR ◆ insider convergence · moderate Child 2023-12-26 9 days — $1K–$15K 8.6 ↗ filing
Rohit Khanna House BUY OCR ◆ insider convergence · moderate Spouse 2023-12-26 9 days — $1K–$15K 8.6 ↗ filing
Rohit Khanna House SELL OCR ◆ insider divergence · moderate Child 2023-12-05 30 days — $1K–$15K 10.6 ↗ filing
Rohit Khanna House BUY OCR ◆ insider convergence · moderate Child 2023-11-07 28 days — $1K–$15K 15.7 ↗ filing
Rohit Khanna House BUY OCR ◆ insider convergence · moderate Child 2023-11-03 32 days — $1K–$15K 22.3 ↗ filing
Rohit Khanna House BUY OCR ◆ insider convergence · strong Child 2023-10-25 12 days — $1K–$15K 40.4 ↗ filing
Rohit Khanna House BUY OCR ◆ insider convergence · strong Child 2023-10-23 14 days — $1K–$15K 75.9 ↗ filing
Nicholas Taylor House SELL Self · VanAnne Holdings LLC GP > Dagger Management LP > Leonidas Capital, LP 2022-11-28 0 days — $100K–$250K 96.7 ↗ filing
Lois Frankel House SELL Self · Morgan Stanley IRA - X142 2022-07-28 33 days — $1K–$15K
0.3% of NW
15.7 ↗ filing
Lois Frankel House SELL Self · Morgan Stanley IRA - X142 2022-06-13 3 days — $1K–$15K
0.3% of NW
22.3 ↗ filing
Lois Frankel House BUY Self 2021-12-10 36 days — $1K–$15K
0.3% of NW
40.4 ↗ filing
Susie Lee House SELL Joint · DSL Living Trust > Bank of New York Brokerage Account 340 2021-09-30 317 days — $15K–$50K
0.6% of NW
20.1 ↗ filing
Susie Lee House BUY Joint 2021-06-28 3 days — $1K–$15K
0.2% of NW
8.6 ↗ filing
Susie Lee House BUY Joint 2020-12-16 16 days — $1K–$15K
0.2% of NW
10.6 ↗ filing
Susie Lee House BUY Joint 2020-12-08 24 days — $1K–$15K
0.2% of NW
15.7 ↗ filing
Susie Lee House BUY Joint 2020-12-03 29 days — $1K–$15K
0.2% of NW
22.3 ↗ filing
Lois Frankel House SELL Self 2020-04-27 0 days — $1K–$15K
0.3% of NW
86.8 ↗ filing
Susie Lee House SELL Joint 2020-04-03 28 days — $1K–$15K
0.2% of NW
52.4 ↗ filing
Susie Lee House BUY Joint 2019-03-20 12 days — $1K–$15K
0.2% of NW
75.9 ↗ filing
David McKinley House SELL Self 2018-12-17 14 days — $15K–$50K 56.6 ↗ filing
Alan Lowenthal House BUY ◆ insider convergence · moderate Spouse 2018-03-08 7 days — $15K–$50K 90.9 ↗ filing
Alan Lowenthal House BUY ◆ insider convergence · moderate Self 2018-03-08 7 days — $1K–$15K 75.9 ↗ filing
David McKinley House BUY Self 2017-09-14 16 days — $15K–$50K 90.9 ↗ filing
Cheri Bustos House SELL Self 2017-01-30 3 days — $15K–$50K 58.5 ↗ filing
Cheri Bustos House BUY Self 2016-05-26 7 days — $15K–$50K 92.1 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in ZBH — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

16
Congress trades with insider convergence
8
…with insider divergence
28
Insider open-market trades

Of the congressional trades in ZBH, 16 coincided with corporate insiders moving the same way within 60 days, and 8 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-09-11 Thornal Kevin R Other SELL $529K ↗ EDGAR
2026-09-04 Phipps Chad F Other SELL $295K ↗ EDGAR
2026-05-29 Yi Sang C-suite SELL $347K ↗ EDGAR
2026-05-29 Yi Sang C-suite SELL $66K ↗ EDGAR
2026-03-12 Winkler Lori Other SELL $251K ↗ EDGAR
2026-02-12 Yi Sang C-suite SELL $96K ↗ EDGAR
2025-09-11 Yi Sang C-suite SELL $124K ↗ EDGAR
2025-09-08 Winkler Lori Other SELL $156K ↗ EDGAR
2025-08-18 Winkler Lori Other SELL $154K ↗ EDGAR
2025-06-13 Yi Sang C-suite SELL $74K ↗ EDGAR
2025-06-11 Yi Sang C-suite SELL $95K ↗ EDGAR
2025-03-05 Winkler Lori Other SELL $151K ↗ EDGAR
2024-05-31 Yi Sang C-suite SELL $1.5M ↗ EDGAR
2024-03-07 Yi Sang C-suite SELL $216K ↗ EDGAR
2024-02-22 Phipps Chad F Other SELL $3.3M ↗ EDGAR
2024-02-22 Phipps Chad F Other SELL $79K ↗ EDGAR
2023-11-09 Jafry Syed A. Director BUY $224K ↗ EDGAR
2023-08-30 Kolli Sreelakshmi Director BUY $120K ↗ EDGAR
2023-08-28 HAGEMANN ROBERT Director BUY $233K ↗ EDGAR
2023-08-28 BEGLEY CHRISTOPHER B Director BUY $117K ↗ EDGAR
2023-08-25 BERNARD BETSY J Director BUY $100K ↗ EDGAR
2023-08-25 MICHELSON MICHAEL W Director BUY $150K ↗ EDGAR
2023-08-23 HIGGINS ARTHUR J Director BUY $58K ↗ EDGAR
2023-08-23 HIGGINS ARTHUR J Director BUY $57K ↗ EDGAR
2023-03-17 Phipps Chad F Other SELL 10b5-1 $2.5M ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
Congress 2026-09-14 Rohit Khanna SELL $1K–$15K
Congress 2026-09-11 Rohit Khanna BUY $1K–$15K
◆ insider 2026-09-11 Thornal Kevin R Other SELL $529K
◆ insider 2026-09-04 Phipps Chad F Other SELL $295K
Congress 2026-07-23 Rohit Khanna SELL $1K–$15K
Congress 2026-07-06 Rohit Khanna SELL $1K–$15K
◆ insider 2026-05-29 Yi Sang C-suite SELL $347K
◆ insider 2026-05-29 Yi Sang C-suite SELL $66K
Congress 2026-03-27 Alan Armstrong BUY $1K–$15K
◆ insider 2026-03-12 Winkler Lori Other SELL $251K
Congress 2026-02-17 Rohit Khanna SELL $1K–$15K
◆ insider 2026-02-12 Yi Sang C-suite SELL $96K
◆ insider 2025-09-11 Yi Sang C-suite SELL $124K
◆ insider 2025-09-08 Winkler Lori Other SELL $156K
◆ insider 2025-08-18 Winkler Lori Other SELL $154K
Congress 2025-07-09 Rohit Khanna BUY $1K–$15K
◆ insider 2025-06-13 Yi Sang C-suite SELL $74K
◆ insider 2025-06-11 Yi Sang C-suite SELL $95K
Congress 2025-06-10 Rohit Khanna BUY $1K–$15K
Congress 2025-05-15 Rob Bresnahan SELL $1K–$15K
Congress 2025-05-02 Rohit Khanna SELL $1K–$15K
Congress 2025-04-08 Rob Bresnahan BUY $1K–$15K
Congress 2025-04-04 Rohit Khanna SELL $1K–$15K
◆ insider 2025-03-05 Winkler Lori Other SELL $151K

FAQ Common questions

How much has Congress traded ZBH?

24 disclosed buys and 17 sells of ZBH (Zimmer Biomet Holdings, Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade ZBH?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.